Subscribe to RSS
DOI: 10.1055/a-2648-9004
Quadruple Layer Technique of Corneal Graft, Amniotic Membrane, and Conjunctiva to Prevent Recurrent Tube Erosion Following Implantation of Glaucoma Drainage Device
Vierfach-Schicht-Technik mit Hornhauttransplantat, Amnionmembran und Bindehaut zur Verhinderung rezidivierender Drainageröhrchenerosion nach Implantation eines Glaukom-Drainageimplantats
Background
Glaucoma drainage devices (GDDs) are an effective treatment option in patients with refractory, secondary, or advanced glaucoma [1]. GDDs consist of a tube that allows aqueous humour to flow from the anterior chamber into a post-equatorial subconjunctival base plate [1]. However, a severe complication associated with GDDs is tube erosion which may lead to hypotony and endophthalmitis [1]. Post-GDD tube erosion is believed to result from a combination of inflammatory, mechanical, and ischemic factors triggered by the foreign body presence of the tube and the associated surgical trauma [2], [3].
To mitigate the risk of tube erosion, the tube may be covered with a patch of biocompatible material, such as donor sclera, pericardium, cornea, or fascia lata [4]. The incidence of post-GDD tube erosions ranges from 0 – 12% in previous studies [3], [4]. To date, ongoing research aims to find a consensus on which patch material might be superior in terms of longevity, safety, and biocompatibility.
Revision surgeries for eroded tubes typically involve replacing the donor patch and covering it with conjunctiva. However, in patients with multiple previous ocular surgeries, conjunctival closure can be difficult to achieve due to conjunctival fragility and its firm adherence to the underlying scar tissue [5]. GDDs might have to be explanted despite good IOP lowering effects due to recurrent erosions and associated risks. Thus, there is an unmet need to address recurrent erosions in these patients avoiding tube explanting.
Amniotic membrane (AM), the innermost layer of the placenta, consists of a single epithelial layer, a thick basement membrane, and an avascular stromal matrix [6]. AM contains growth factors and anti-inflammatory cytokines, which promotes epithelialization, reduces fibrosis, and modulates the immune response [7]. Additionally, its high tensile strength, biocompatibility, and ability to integrate into host tissues make AM a suitable option for patching of tubes in GDD surgery [7]. Previous studies have shown that AM patches can improve surgical outcomes of GDD surgeries, especially in eyes with compromised conjunctiva [8]. We present, for the first time, a quadruple layer technique involving the use of a corneal graft, a double layer of amniotic membrane (AM), and conjunctiva to patch the tube of a Paul glaucoma drainage device (GDD) in a patient with recurrent tube erosions.
Publication History
Received: 08 December 2024
Accepted: 26 June 2025
Article published online:
01 September 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Hong CH, Arosemena A, Zurakowski D. et al. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 2005; 50: 48-60
- 2 Chaku M, Netland PA, Ishida K. et al. Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery. Clin Ophthalmol 2016; 10: 547-553
- 3 Stewart WC, Kristoffersen CJ, Demos CM. et al. Incidence of conjunctival exposure following drainage device implantation in patients with glaucoma. Eur J Ophthalmol 2010; 20: 124-130
- 4 Levinson JD, Giangiacomo AL, Beck AD. et al. Glaucoma drainage devices: risk of exposure and infection. Am J Ophthalmol 2015; 160: 516-521.e2
- 5 Rosentreter A, Lappas A, Widder RA. et al. Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices. BMC Ophthalmol 2018; 18: 60
- 6 Dekaris I, Gabrić N. Preparation and preservation of amniotic membrane. Dev Ophthalmol 2009; 43: 97-104
- 7 Ruiz-Cañada C, Bernabé-García Á, Liarte S. et al. Chronic Wound Healing by Amniotic Membrane: TGF-β and EGF Signaling Modulation in Re-epithelialization. Front Bioeng Biotechnol 2021; 9: 689328
- 8 Ainsworth G, Rotchford A, Dua HS. et al. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br J Ophthalmol 2006; 90: 417-419
- 9 Rahman I, Said DG, Maharajan VS. et al. Amniotic membrane in ophthalmology: indications and limitations. Eye (Lond) 2009; 23: 1954-1961
- 10 Anand A, Sheha H, Teng CC. et al. Use of amniotic membrane graft in glaucoma shunt surgery. Ophthalmic Surg Lasers Imaging 2011; 42: 184-189